| Date Filed | Type | Description |
| 06/12/2023 |
4
| Scott Randal W. (Director) has filed a Form 4 on Talis Biomedical Corp|
Txns:
| Granted 95,000 options to buy
@ $0.5, valued at
$47.5k
|
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/24/2022 |
4
| Scott Randal W. (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 104,921 options to buy
@ $8.45, valued at
$886.6k
|
|
| 06/13/2022 |
4
| Scott Randal W. (Director) has filed a Form 4 on Talis Biomedical Corp|
Txns:
| Granted 95,000 options to buy
@ $1, valued at
$95k
|
|
| 06/22/2021 |
4
| Scott Randal W. (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 38,895 options to buy
@ $62.63, valued at
$2.4M
|
|
| 05/18/2021 |
4
| Scott Randal W. (Director) has filed a Form 4 on Talis Biomedical Corp|
Txns:
| Bought 9,000 shares
@ $10.16, valued at
$91.4k
Bought 11,000 shares
@ $10.11, valued at
$111.2k
|
|
| 02/19/2021 |
4
| Scott Randal W. (Director) has filed a Form 4 on Talis Biomedical Corp|
Txns:
| Converted 752,897 shares
@ $0
Converted 334,546 shares
@ $0
Converted 302,621 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 1,076,643 preferred shares
@ $0
Converted 478,402 preferred shares
@ $0
Converted 432,749 preferred shares
@ $0 |
|
| 02/18/2021 |
4
| Scott Randal W. (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Bought 16,000 shares
@ $62.5, valued at
$1M
|
|
| 02/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2020 |
4
| Scott Randal W (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 101,223 options to buy
@ $32.62, valued at
$3.3M
|
|
| 06/25/2020 |
3
| Scott Randal W (Director) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 08/27/2019 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on Invitae Corp|
Txns:
| Sold 11,699 shares
@ $24.0174, valued at
$281k
Sold 28,301 shares
@ $24.8198, valued at
$702.4k
|
|
| 05/30/2019 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on Invitae Corp|
Txns:
| Sold 30,000 shares
@ $17.6009, valued at
$528k
|
|
| 05/06/2019 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on Invitae Corp|
Txns:
| Granted 10,000 options to buy
@ $24.16, valued at
$241.6k
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2018 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on Invitae Corp|
Txns:
| Granted 10,000 options to buy
@ $8.08, valued at
$80.8k
|
|
| 04/02/2018 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on Invitae Corp|
Txns:
| Bought 44,444 shares
@ $4.5, valued at
$200k
|
|
| 05/04/2017 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on Invitae Corp |
| 11/22/2016 |
4
| Scott Randal W (Chairman and CEO) has filed a Form 4 on Invitae Corp |
| 02/18/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/15/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/12/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2012 |
4
| Scott Randal W (CEO, InVitae Corporation*) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Sold 14,400 shares
@ $33.7379, valued at
$485.8k
Sold 600 shares
@ $34.56, valued at
$20.7k
Sold 15,000 shares
@ $33.3103, valued at
$499.7k
|
|
| 05/14/2012 |
4
| Scott Randal W (CEO, InVitae Corporation*) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Sold 14,600 shares
@ $29.9224, valued at
$436.9k
Sold 400 shares
@ $30.285, valued at
$12.1k
Sold 7,200 shares
@ $29.9951, valued at
$216k
Sold 5,620 shares
@ $30.8451, valued at
$173.3k
Sold 2,180 shares
@ $31.3891, valued at
$68.4k
|
|
| 04/12/2012 |
4
| Scott Randal W (CEO, InVitae Corporation*) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Sold 9,169 shares
@ $28.7473, valued at
$263.6k
Sold 831 shares
@ $29.4793, valued at
$24.5k
Sold 10,000 shares
@ $28.379, valued at
$283.8k
|
|
| 02/17/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/12/2012 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Sold 10,000 shares
@ $27.353, valued at
$273.5k
Sold 9,900 shares
@ $27.5544, valued at
$272.8k
Sold 100 shares
@ $28.23, valued at
$2.8k
|
|
| 12/14/2011 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Sold 9,900 shares
@ $27.5562, valued at
$272.8k
Sold 100 shares
@ $28.46, valued at
$2.8k
Sold 7,890 shares
@ $26.8773, valued at
$212.1k
Sold 2,110 shares
@ $27.4957, valued at
$58k
|
|
| 12/14/2011 |
4/A
| Scott Randal W (Executive Chairman) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Gifted 5,000 shares
@ $0
Gifted 25,000 shares
@ $0 |
|
| 11/22/2011 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Gifted 5,000 shares
@ $0
Gifted 25,000 shares
@ $0 |
|
| 11/22/2011 |
4
| Scott Randal W (Executive Chairman) has filed a Form 4 on GENOMIC HEALTH INC|
Txns:
| Sold 10,000 shares
@ $23.0608, valued at
$230.6k
Sold 10,000 shares
@ $22.5985, valued at
$226k
|
|
|